Live
- Congress, CPI-M not part of INDIA bloc in Bengal: Mamata Banerjee
- Madhubani Saree: The epitome of traditional elegance and modern beauty
- Fire in TTD Forest in Tirumala
- SC dismisses rape survivor's plea seeking action against Kerala judge
- Chiranjeevi Engages with Russian Delegates on Creative Ventures in Hyderabad
- Has Allu Arjun's ‘Pushpa 2’ raked in Rs. 1000 Crore Pre-Release Business?
- Reports of spat with Netanyahu misleading: Germany
- 5.0-magnitude quake hits Alaska Peninsula
- AP assembly elections: Filing of nominations in full swing in the state
- Alaya F stuns in denim look, exudes boss babe energy
India, EU to meet on Jan 18 in Brussels
India and EU are expected to meet on January 18 in Brussels to iron out issues related to the ban imposed by the latter on around 700 pharma products which were clinically tested by Hyderabad-based GVK Biosciences.
GVK Bio row
New Delhi : India and EU are expected to meet on January 18 in Brussels to iron out issues related to the ban imposed by the latter on around 700 pharma products which were clinically tested by Hyderabad-based GVK Biosciences. Accompanied by industry representatives from Pharmaceuticals Export Promotion Council (PHARMEXCIL), senior officials from the commerce ministry will be visiting Brussels next month.
"Several issues are likely to come up during the meeting, including GVK Biosciences," an official said. The ban imposed by the 28-nation bloc had led to deferment of talks in August between the two sides on the stalled free trade agreement, officially dubbed as Broadbased Investment and Trade Agreement (BTIA), to boost two-way commerce and investment. India had expressed disappointment on the development and stated that the decision was taken unilaterally. The EU had banned the marketing of around 700 generic medicines for alleged manipulation of clinical trials.
